Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study

Despite an increase in 1-year RS in most European regions, the survival of primary malignant brain tumours is still poor. Disparities between countries were evident, being even larger at the end of the study period than at the beginning, suggesting differences in availability of the latest treatment modalities.